{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?page=3&sponsor=Pfizer%27s+Upjohn+has+merged+with+Mylan+to+form+Viatris+Inc.", "query": { "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 158, "total_pages": 16, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=4&sponsor=Pfizer%27s+Upjohn+has+merged+with+Mylan+to+form+Viatris+Inc.&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=2&sponsor=Pfizer%27s+Upjohn+has+merged+with+Mylan+to+form+Viatris+Inc.&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-13T02:37:24.722Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00645268", "title": "A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Erectile Dysfunction", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "sildenafil", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "70 Years", "sex": "MALE", "summary": "35 Years to 70 Years · Male only" }, "enrollment_count": 300, "start_date": "2002-12", "completion_date": "2004-01", "has_results": false, "last_update_posted_date": "2021-02-01", "last_synced_at": "2026-10-13T02:37:24.722Z", "location_count": 28, "location_summary": "Huntsville, Alabama • Phoenix, Arizona • Beverly Hills, California + 21 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Duarte", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00645268" }, { "nct_id": "NCT00139776", "title": "Study Of \"Continuous Use\" Of Celecoxib Vs. \"Usual or Intermittent Use\"", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Osteoarthritis, Knee", "Osteoarthritis, Hip" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 875, "start_date": "2005-07", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2021-03-29", "last_synced_at": "2026-10-13T02:37:24.722Z", "location_count": 67, "location_summary": "Huntsville, Alabama • Peoria, Arizona • Phoenix, Arizona + 58 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00139776" }, { "nct_id": "NCT00343200", "title": "A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Impotence" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Viagra (sildenafil citrate)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "MALE", "summary": "30 Years and older · Male only" }, "enrollment_count": 371, "start_date": "2006-07", "completion_date": "2007-09", "has_results": false, "last_update_posted_date": "2021-02-01", "last_synced_at": "2026-10-13T02:37:24.722Z", "location_count": 48, "location_summary": "Huntsville, Alabama • Mesa, Arizona • Phoenix, Arizona + 42 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00343200" }, { "nct_id": "NCT00359151", "title": "Celebrex Total Knee Arthroplasty Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Osteoarthritis", "Pain" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 22, "start_date": "2006-11", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2021-03-03", "last_synced_at": "2026-10-13T02:37:24.722Z", "location_count": 7, "location_summary": "Aurora, Colorado • Englewood, Colorado • Chicago, Illinois + 3 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00359151" }, { "nct_id": "NCT02072824", "title": "A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Partial Onset Seizures" ], "interventions": [ { "name": "Pregabalin Dose Level 1", "type": "DRUG" }, { "name": "Pregabalin Dose Level 2", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "3 Years", "sex": "ALL", "summary": "1 Month to 3 Years" }, "enrollment_count": 175, "start_date": "2014-09-16", "completion_date": "2018-03-13", "has_results": true, "last_update_posted_date": "2021-01-20", "last_synced_at": "2026-10-13T02:37:24.722Z", "location_count": 5, "location_summary": "Orlando, Florida • Tampa, Florida • Houston, Texas + 1 more", "locations": [ { "city": "Orlando", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Houston", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02072824" }, { "nct_id": "NCT00406315", "title": "Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder" ], "interventions": [ { "name": "ziprasidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 255, "start_date": "2006-11", "completion_date": "2009-03", "has_results": true, "last_update_posted_date": "2021-03-29", "last_synced_at": "2026-10-13T02:37:24.722Z", "location_count": 28, "location_summary": "Phoenix, Arizona • Costa Mesa, California • Garden Grove, California + 23 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00406315" }, { "nct_id": "NCT00343655", "title": "Evaluation of Atorvastatin Treatment on Carotid Plaque.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Diseases" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 160, "start_date": "2007-01", "completion_date": "2007-08", "has_results": false, "last_update_posted_date": "2021-02-18", "last_synced_at": "2026-10-13T02:37:24.722Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00343655" }, { "nct_id": "NCT00147654", "title": "Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Urinary Incontinence" ], "interventions": [ { "name": "Tolterodine ER 4 mg QD", "type": "DRUG" }, { "name": "Tamsulosin 0.4 mg QD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "MALE", "summary": "40 Years and older · Male only" }, "enrollment_count": 830, "start_date": "2004-11", "completion_date": "2006-05", "has_results": false, "last_update_posted_date": "2021-01-27", "last_synced_at": "2026-10-13T02:37:24.722Z", "location_count": 95, "location_summary": "Birmingham, Alabama • Homewood, Alabama • Tucson, Arizona + 92 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Homewood", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Culver City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00147654" }, { "nct_id": "NCT02060487", "title": "Effects of Oral Sildenafil on Mortality in Adults With PAH", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Arterial Hypertension" ], "interventions": [ { "name": "sildenafil citrate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 385, "start_date": "2014-09-22", "completion_date": "2021-02-26", "has_results": true, "last_update_posted_date": "2022-05-13", "last_synced_at": "2026-10-13T02:37:24.722Z", "location_count": 11, "location_summary": "Atlanta, Georgia • Grand Rapids, Michigan • Wooster, Ohio + 2 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Grand Rapids", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02060487" }, { "nct_id": "NCT00883740", "title": "Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fibromyalgia", "Sleep Disorders" ], "interventions": [ { "name": "Pregabalin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 119, "start_date": "2009-06", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2021-01-25", "last_synced_at": "2026-10-13T02:37:24.722Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Tucson, Arizona • San Diego, California + 22 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00883740" } ] }